In total, anti-VEGF drugs, including bevacizumab, conbercept, and ranibizumab, were given to 3 eyes of 2 BVMD patients and 4 eyes of 2 ARB patients, especially those that also exhibited CNV or retinoschisis. Here, VEGFA is linked to retinoschisis.